Unveiling the Potential Drug Target and Biomarker, CXorf65, in Chromosome X Open Reading Frame 65

Target Name: CXorf65

NCBI ID: G158830

CXorf65

Other Name(s): chromosome X open reading frame 65 | CX065_HUMAN | Uncharacterized protein CXorf65 | CXorf65 variant 1 | Chromosome X open reading frame 65, transcript variant 1

Unveiling the Potential Drug Target and Biomarker, CXorf65, in Chromosome X Open Reading Frame 65

Introduction

Chromosome X is one of the human chromosomes responsible for maintaining genetic diversity and has been implicated in various human diseases. The Open Reading Frame (ORF) is a regions of DNA that are involved in protein synthesis and have been identified as potential drug targets or biomarkers . Chromosome X Open Reading Frame 65 (CXorf65) is a specific ORF that is known to be involved in various cellular processes, and its function and potential as a drug target or biomarker has been the focus of intense research in recent years.

CXorf65: Structure and Expression

CXorf65 is a 21 kDa protein that is located on chromosome X open reading frame 65. It consists of 1,940 amino acids, including two conserved base interaction sites (the conserved amino acid residues are Glu-112, Glu-113, Glu-114, Asn-115, Asn-116, Glu-117, Asp-118, Asp-119, Glu-120, Glu-121, Asp-122, Asp-123, Glu-124, Glu-125, Glu-126, Glu-127, Asp-128, Glu-129, Glu- 130, Glu-131, Asp-132, Asp-133, Glu-134, Glu-135, Asp-136, Asp-137, Glu-138, Asp-139, Glu-140, Glu-141, Asp-142, Asp-143, Glu-144, Asp-145, Glu-146, Asp-147, Glu-148, Asp-149, Glu-150, Asp-151, Asp-152, Glu-153, Asp-154, Asp- 155, Glu-156, Asp-157, Glu-158, Asp-159, Glu-160, Asp-161, Asp-162, Glu-163, Asp-164, Asp-165, Glu-166, Asp-167, Glu-168, Asp-169, Glu-170, Asp-171, Asp-172, Glu-173, Asp-174, Asp-175, Glu-176, Asp-177, Asp-178, Glu-179, Asp- 180, Asp-181, Asp-182, Glu-183, Asp-184, Asp-185, Glu-186, Asp-187, Glu-188, Asp-189, Glu-190, Asp-191, Asp-192, Glu-193, Asp-194, Asp-195, Glu-196, Asp-197, Glu-198, Asp-199, Glu-200, Asp-201, Asp-202, Glu-203, Asp-204, Asp- 205, Glu-206, Asp-207, Glu-208, Asp-209, Glu-210, Asp-211, Asp-212, Glu-213, Asp-214, Asp-215, Glu-216, Asp-217, Glu-218, Asp-219, Glu-220, Asp-221, Asp-222, Glu-223, Asp-224, Asp-225, Glu-226, Asp-227, Glu-228, Asp-229, Glu- 230, Asp-231, Asp-232, Glu-233, Asp-234, Asp-235, Glu-236, Asp-237, Glu-238, Asp-239, Glu-240, Asp-241, Asp-242, Glu-243, Asp-244, Asp-245, Glu-246, Asp-247, Glu-248, Asp-249, Glu-250, Asp-251, Asp-252, Glu-253, Asp-254, Asp- 255, Glu-256, Asp-257, Glu-258, Asp-259, Glu-260, Asp-261, Asp-262, Glu-263, Asp-264, Asp-265, Glu-266, Asp-267, Glu-268, Asp-269, Glu-270, Asp-271, Asp-272, Glu-273, Asp-274, Asp-275, Glu-276, Asp-277, Asp-278, Glu-279, Asp- 280, Asp-281, Asp-282, Glu-283, Asp-284, Asp-285, Glu-286, Asp-287, Glu-288, Asp-289, Glu-290, Asp-291, Asp-292, Glu-293, Asp-294, Asp-295, Glu-296, Asp-297, Glu-298, Asp-299, Glu-300, Asp-301, Asp-302, Glu-303, Asp-304, Asp- 305, Glu-306, Asp-307, Glu-308, Asp-309, Glu-310, Asp-311, Asp-312, Glu-313, Asp-314, Asp-315, Glu-316, Asp-317, Glu-318, Asp-319, Glu-320, Asp-321, Asp-322, Glu-323, Asp-324, Asp-325, Glu-326, Asp-327, Glu-328, Asp-329, Glu- 330, Asp-331, Asp-332, Glu-333, Asp-334, Asp-335, Glu-336, Asp-337, Glu-338, Asp-339, Glu-340, Asp-341, Asp-342, Glu-343, Asp-344, Asp-345, Glu-346, Asp-347, Glu-348, Asp-349, Glu-350, Asp-351, Asp-352, Glu-353, Asp-354, Asp- 355, Glu-356, Asp-357, Glu-358, Asp-359, Glu-360, Asp-361, Asp-362, Glu-363, Asp

Protein Name: Chromosome X Open Reading Frame 65

The "CXorf65 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CXorf65 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets